1Min H,Morony S,Sarosi I,et al.Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis[J].J Exp Med,2000,192(4):463-474. 被引量：1
2Vattikuti R,Towler DA.Osteogenic regulation of vascular calcification:an early perspective[J].Am J Physiol Endocrinol Metab,2004,286(5):E686-696. 被引量：1
3Morena M,Terrier N,Jaussent I,et al.Plasma osteoprotegerin is associated with mortality in hemodialysis patients[J].J Am Soc Nephrol,2006,17(1):262-270. 被引量：1
4Rhee EJ,Lee WY,Kim SY,et al.Relationship of serum osteoprotegerin levels with coronary artery disease severity,left ventricular hypertrophy and C-reactive protein[J].Clin Sci (Lond),2005,108(3):237-243. 被引量：1
5Moe SM,Reslerova M,Ketteler M,et al.Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD)[J].Kidney Int,2005,67:2295-2304. 被引量：1
6Avignon A,Sultan A,Piot C,et al.Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients[J].Diabetes Care,2005,28(9):2176. 被引量：1
7Hermann-Arnhof KM,Kastenbauer T,Publig T,et al.Initially elevated osteoprotegerin serum levels may predict a perioperative myocardial lesion in patients undergoing coronary artery bypass grafting[J].Crit Care Med,2006,34(1):76-80. 被引量：1
8Crisafulli A,Micari A,Altavilla D,et al.Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction[J].Clin Sci (Lond),2005,109(4):389-395. 被引量：1
9Olesen P,Ledet T,Rasmussen LM.Arterial osteoprotegerin:increased amounts in diabetes and modifiable synthesis from vascular smooth muscle cells by insulin and TNF-alpha[J].Diabetologia,2005,48(3):561-568. 被引量：1
10Knudsen ST,Foss CH,Poulsen PL,et al.Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications[J].Eur J Endocrinol,2003,149(1):39-42. 被引量：1
